Tranexamic Acid Production Cost Reports

The report provides a detailed analysis essential for establishing a Tranexamic Acid production plant. It encompasses all critical aspects necessary for Tranexamic Acid production, including the cost of Tranexamic Acid production, Tranexamic Acid plant cost, Tranexamic Acid production costs, and the overall Tranexamic Acid production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Tranexamic Acid production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Tranexamic acid is a medicine that helps stop heavy bleeding by preventing blood clots from breaking down too quickly. It works by helping your body keep the clots it forms, which reduces the amount of blood lost during events like heavy periods, surgery, or injuries. It is taken as a pill, injection, or mouthwash and is used to treat bleeding from many causes, like nosebleeds, dental procedures, and certain medical conditions.

It is a popular choice because it is well-tolerated, affordable, and can significantly reduce the need for blood transfusions. It is also utilised to control bleeding complications in major trauma or heart surgery patients. It is employed as an essential drug in emergency medicine, orthopaedics, gynaecology, and dentistry. Its common side effects include headache, nasal or sinus symptoms, back pain, stomach pain, muscle or joint pain, tiredness, and mild anaemia.

The market for tranexamic acid is driven by its increasing demand in surgical procedures and the rising prevalence of bleeding disorders. Also, its expanding use in trauma care and heavy menstrual bleeding, and growing adoption in cosmetic and dermatological treatments contribute to its demand. The rise in awareness and its usage in obstetrics to manage postpartum haemorrhage (a leading cause of maternal mortality) further fuels market growth.  The industrial tranexamic acid procurement is influenced by regulatory compliance with strict documentation (like valid DMF, GMP certificates) for high purity and pharmaceutical-grade quality (USP, EP, JP grades). Also, supplier reliability with proven production experience, inventory management, and changes in regional demand affect its sourcing.

Raw Material for Tranexamic Acid Production

According to the Tranexamic Acid production plant project report, the key raw materials used in the production of Tranexamic Acid include 4-Methylbenzonitrile-Hydrogen Gas-Raney Nickel Catalyst, and Platinum Catalyst.

Production Process of Tranexamic Acid

The extensive Tranexamic Acid production cost report consists of the following major industrial production process:

1. From 4-Methylbenzonitrile: The production process of Tranexamic acid starts from 4-methylbenzonitrile. In this process, the oxidation of the methyl group on 4-methylbenzonitrile takes place, which gives a mononitrile derivative of terephthalic acid. After that, the cyano group in this intermediate goes through catalytic hydrogenation using Raney nickel as the catalyst, which leads to the formation of 4-aminomethylbenzoic acid. This aromatic compound is further hydrogenated using a platinum catalyst, which reduces the benzene ring to a cyclohexane ring, giving a mixture of isomeric 4-aminomethylcyclohexane carboxylic acids. The crude tranexamic acid is separated and purified to get pure tranexamic acid as the final product.

Tranexamic acid is a white or almost white crystalline powder with the molecular formula C8H15NO2 and a molecular weight of 157.21 g/mol. It has a melting point above 300 degree Celsius. It is freely soluble in water and glacial acetic acid, slightly soluble in ethanol, and almost insoluble in ether. It has a density of about 1.08 g/cm³ and a vapour pressure of 1.72 hPa. Its pKa values are around 4.3 and 10.6, showing the presence of acidic and basic functional groups. It has a cyclohexane ring substituted with an aminomethyl and a carboxylic acid group, making it a lysine derivative. It is stable under normal storage conditions (2–8 degree Celsius), and it is hygroscopic. It works as an antifibrinolytic agent by binding to lysine sites on plasminogen, preventing fibrin clot breakdown.